Highlights  Lmo3 deficiency is associated with alterations in emotional behavior  Absence of Lmo3 impairs amygdala LTP  Amygdala transcriptome is selectively altered in Lmo3-deficient mice J o u r n a l P r e -p r o o f Abstract The highly conserved transcription factor LIM-only 3 (Lmo3) is involved in important neurodevelopmental processes in several brain areas including the amygdala, a central hub for the generation and regulation of emotions. Accordingly, a role for Lmo3 in the behavioral responses to ethanol and in the display of anxiety-like behavior in mice has been demonstrated while the potential involvement of Lmo3 in the control of mood-related behavior has not yet been explored. Using a mouse model of Lmo3 depletion (Lmo3 z ), we here report that genetic Lmo3 deficiency is associated with altered performance in behavioral paradigms assessing anxietylike and depression-like traits and additionally accompanied by impairments in learned fear. Importantly, long-term potentiation (LTP) in the basolateral amygdala (BLA), a proposed cellular correlate of fear learning, is impaired in Lmo3 z mice. RNA-Sequencing analysis of BLA tissue and gene set enrichment analysis (GSEA) of differentially expressed genes in Lmo3 z mice reveals a significant overlap between genes overexpressed in Lmo3 z mice and those enriched in the amygdala of a cohort of patients suffering from major depressive disorder.
and has been strongly implicated in the neural circuitry involved in the pathogenesis of several neuropsychiatric disorders (Drevets, 2003; Mahan and Ressler, 2012; Rauch et al., 2003) . Against this background, and in light of the strong expression of Lmo3 in the basolateral nucleus of the amygdala (BLA), selected emotional functions have been assessed in an Lmo3 transgenic mouse model (Lasek et al., 2011; Savarese et al., 2014; Savarese and Lasek, 2018) . These studies have revealed an involvement of Lmo3 in the behavioral responses to ethanol and in the regulation of anxiety-like behavior in mice. Due to the high degree of comorbidity between substance abuse, anxiety and mood disorders, a potential role for Lmo3 in the control of mood-related behavioral phenotypes is also conceivable. Additionally, Lmo3 is a potent regulator for adipogenesis in humans (Lindroos et al., 2013) and epidemiological studies have highlighted a bidirectional link between obesity/ metabolic syndrome and depression in people (Anderson et al., 2001; Luppino et al., 2010; Pan et al., 2012) . These observations lend further support to a possible link between Lmo3 activity and mood disorders. However, a potential involvement of Lmo3 in the modulation of mood-related behavior has not yet been experimentally addressed.
We therefore set out to comprehensively assess the consequences of genetic Lmo3 deficiency (Lmo3 z mice) for emotional behavior in the mouse, including the characterization of several phenotypes associated with depression-like traits. In order to shed first light on the potential cellular and molecular mechanisms underlying the involvement of Lmo3 in emotional behavior, we focussed on the amygdala and the investigation of neural activity and gene expression patterns in Lmo3 z mice. 
Animals
Lmo3 knockout mice (Lmo3 z ) were generated via the insertion of IRES-LacZ into exon 2 of the Lmo3 gene, as previously described elsewhere (Savarese et al., 2014; Savarese and Lasek, 2018; Tse et al., 2004) . Heterozygous breeding pairs were generously provided by Amy W.
Lasek (Department of Psychiatry, University of Illinois at Chicago). Homozygous Lmo3 z mice and age-matched (8-14 weeks old at onset of experiments) wild-type (WT) littermates of both sexes were used for experiments. Mice were kept group housed and had ad libitum access to standard chow and water, unless otherwise indicated. Separate cohorts of mice were used for each of the following: all behavioral tests, electrophysiology, and RNA-Sequencing. For confirmation of sequencing results by qRT-PCR, the original set of samples was complemented by RNA derived from additional Lmo3 z and WT mice. All animal experiments were carried out according to the EU Directive 2010/63/EU and the local law (Tierversuchsgesetz 2012) regulating the use and care of laboratory animals in research.
Behavioral experiments
All mice were single-housed for one week prior to the start of behavioral experiments. All behavioral experiments were performed during the light phase of the light-dark cycle (12 h light: 12 h dark). Mice were allowed to habituate to the experimental room for 45-60 minutes prior to the start of testing. The tests were performed in order of ascending stress severity and with a minimum of 24 hours of rest between tests, as shown in the timeline in Supplementary Figure S1.
Light-Dark box test (LDB)
LDB was conducted according to a previously published protocol (Reisinger et al., 2018) using laser-beam fitted arenas, opaque inserts for the dark compartment and Activity Monitor software (MedAssociates, Fairfax, Vermont, USA). Briefly, mice were placed in the dark compartment (illuminance: < 5 lx) of a two-compartment light-dark box in which they were free to roam for 10 minutes while their movements were tracked. The percentage of distance travelled (relative to the total distance travelled during the test) in the light compartment (illuminance: 300 lx) was used as indicator of anxiety-like behavior.
Elevated plus maze (EPM)
For the EPM (Reisinger et al., 2018) , mice were placed into the center of a plus-shaped maze consisting of two opposing closed arms (with ~20 cm opaque walls; illuminance 10 lx) and J o u r n a l P r e -p r o o f two opposing open arms (illuminance 100 lx), with the maze itself being elevated approximately 50 cm above the ground. A trial lasted for 5 minutes, during which all movements were tracked using a camera and the software Videotrack (Viewpoint, Champagne au Mont d'Or, France). Anxiety-like behavior was determined by calculating the percentage of distance travelled in the open arms relative to the total distance covered.
Open Field Test (OFT)
During the OFT, mice were placed into the corner of a brightly-lit laser-beam fitted arena (27.3 x 27.3 cm 2 ; MedAssociates, Fairfax, Vermont, USA; illuminance 300 lx) and allowed to explore for fifteen minutes. The % of distance covered in the center (defined as a square measuring a quarter of the surface area of the arena; distance from walls ~ 6.825 cm) of the arena (compared to total locomotor activity exhibited during this test), was used as indicator of anxiety-like behavior.
Fear Conditioning (FC)
A standard Pavlovian conditioning protocol was employed as previously reported (Ronovsky et al., 2019) . Briefly, mice were handled by the experimenter on the two days directly preceding the start of the FC paradigm. On trial days, mice were allowed to habituate for approximately 45 minutes in a holding room adjacent to the experimental room. During training sessions of 6 minutes each on two consecutive days, an unconditioned stimulus (US: foot shock, 0.6 mA) was paired twice with a conditioned stimulus (CS: white noise, 75 dB).
Cued recall was tested 24 hours after the second conditioning session, and was evaluated by measuring the difference between freezing levels before and during the presentation of the CS (preCS-CS) in a test trial lasting 210 seconds in total, with the preCS phase being 60 seconds long while the CS was presented for 30 seconds (A-B-A design). Freezing behavior (percentage of time spent freezing, defined as lack of movement for at least 0.5 seconds, or 15 frames at a sampling rate of 30 frames/s) was automatically recorded using the 'NIR Video Fear Conditioning Contextual Package for Mouse' system and accompanying Video Freeze software (both MedAssociates, Fairfax, Vermont, USA).
Sucrose Preference Test (SPT)
In the SPT, anhedonic behavior was evaluated by measuring the total volume of sucrose (mL/kg body weight) consumed during a 3-hour two-bottle choice test (Reisinger et al., 2018) , where mice could choose between tap water and sucrose (2% in tap water, Sigma Aldrich, Vienna, Austria). 72 hours prior to the test, mice were habituated to the taste of sucrose in a training phase lasting 48 hours, where tap drinking water was replaced with 2% sucrose the home cage of each mouse. Following this training phase, mice were allowed access to tap water again for six hours, before an 18-hour food-and water-restriction phase immediately prior to testing.
Novelty Suppressed Feeding Test (NSF)
Levels of depression-related anxiety behavior were determined using the NSF (Reisinger et al., 2018) . Briefly, during the test mice were placed into the corner of a brightly illuminated arena (30 x 50 cm 2 ; illuminance 800 lx) filled with standard bedding material, at the center of which a single food pellet was placed. The length of time until feeding started (latency to bite, s) was recorded for each animal by the experimenter. To enhance the motivation to feed under these adverse conditions, mice were food-restricted for 24 hours prior to the test. Weight loss (%) during this period was measured and compared between groups.
Furthermore, home cage food consumption in the five minutes immediately following the test was evaluated.
Forced Swim Test (FST)
The FST was used to evaluate depression-related behavioral despair (Porsolt et al., 1977) .
According to an established procedure (Reisinger et al., 2018) , each mouse was placed into a transparent beaker (~ 30 cm high), partially filled with tap water (22 ± 1 °C), for 6 minutes and all movements were video-recorded and analyzed using the software Videotrack (Viewpoint, Champagne au Mont d'Or, France). Average immobility (%, defined as the absence of movement apart from the ones necessary to keep afloat) was calculated for the final four minutes of the test and used as indicator of behavioral despair.
Electrophysiology
Input/output and long-term synaptic potentiation protocols were performed in coronal slices (300 µm) containing the basolateral amygdala (BLA) according to a previously published procedure (Ronovsky et al., 2019) . Male and female mice were anesthetized by 7 vibrating microtome (model 7000smz-2, Campden Instruments Ltd., Loughborough, UK) while submerged in ice-cold cutting solution under constant perfusion with a carbogen gas mixture (95% O2/5% CO2). Slices were then transferred to aCSF solution (NaCl 118 mM; KCl 2.5 mM; NaH2PO4 1 mM; NaHCO3 26.2 mM; glucose 20 mM; CaCl2 2 mM; MgCl2 1 mM), still under carbogen perfusion, and left to rest for at least 60 minutes at 33 °C. Slices were individually moved to the recording chamber superfused with carbogenated aCSF. Electrical stimulation was delivered via the lateral nucleus of the amygdala, immediately ventral to cortical afferent fibres, using a custom-built bipolar tungsten electrode insulated to the tip and an ISO-STIM 01D isolator stimulator (NPI Electronics, Tamm, Germany). Recording pipettes were prepared using borosilicate glass capillaries and a horizontal puller (Sutter Instrument, Novato, CA, USA), filled with aCSF (resistance 3 ± 1 MΩ) and positioned to record at the superior part of the BLA (Wiltgen et al., 2009 ). An AxoClamp-2B amplifier (bridge mode) and a Digidata 1550A interface (both from Axon Instruments, Molecular Devices, San Jose, CA, USA) were used for all recording experiments.
Input/output curves were obtained in order to assess basal synaptic strength by evaluating changes in fEPSP slopes upon stimulation with increasing steps of voltage (0-7 V, 1 V increments, 200 μs). For LTP experiments, stable baseline fEPSPs were recorded for at least 10 minutes using a stimulation intensity that elicited ̴ 30% of the maximal input/output value previously determined (200 µs; 0.03 Hz). The LTP induction protocol consisted of two trains of high-frequency stimulation (0.5 s; 100 Hz; 200 μs/pulse, inter-train interval: 10s) using the same input stimulation intensity. Resulting fEPSPs were recorded for a minimum of 30 minutes. To assess synaptic strengthening following LTP induction, changes in the linear slope decays of fEPSPs were determined and normalized to baseline values. All recordings and raw data analyses were performed using functions of the software pClamp10 (Molecular Devices, San Jose, CA, USA).
Brain extraction and sample preparation
Female Lmo3 z and WT mice were sacrificed by cervical dislocation and their brains were extracted on ice. Whole brains were placed into Tissue-Tek O.C.T. medium (Sakura Finetek, Staufen im Breisgau, Germany), frozen, and stored at -80 °C until further processing.
Basolateral amygdala (BLA) micropunches
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After thawing, brains were cut using a cryostat (Leica Biosystems, Wetzlar, Germany) at a cutting temperature of -6 °C to -10 °C. Three consecutive coronal sections containing the BLA (300 μM thickness) were collected from Bregma -0.94 mm to Bregma -1.84 mm (Paxinos, 2013) . In each of these sections, the BLA was collected bilaterally using stainless steel cannulas (diameter 0.69 mm), placed directly into 700 μL Qiazol (Qiagen, Venlo, Netherlands) and vortexed until the tissue was homogenized (~ 30 s). This mixture was then flash-frozen and stored at -80 °C until RNA extraction (approximately 4 weeks).
RNA extraction
Total RNA extraction of BLA tissue was performed using the Qiagen miRNeasy Micro Kit (Qiagen, Venlo, Netherlands) following the manufacturer's supplied protocol apart from the first step of homogenizing the tissue in Qiazol upon defrosting: Instead, the tissue was homogenized in Qiazol just prior to freezing as described in the previous section, and the homogenate incubation period of 5 minutes was started as soon as the homogenate was fully thawed. All other steps were precisely followed as per the protocol.
qRT-PCR
qRT-PCR was performed as previously described (Lindroos et al., 2013) . All expression data are normalized to amounts of acidic ribosomal phosphoprotein P0 (RPLP0). Primer sequences are as follows:
Rplp0 (forward: GCCAATAAGGTGCCAGCTGCTG, reverse: GAAGGAGGTCTTCTCGGGTCCTAG); Lmo3 (forward: GCATGAGGACTGCCTGAAGTG; reverse: GCCTTCGTGTACAAGGTGGAG); (Schmidt et al., 2018) . Briefly, sequencing libraries were prepared using the NEBNext® Ultra™ II RNA Library Prep Kit according to manufacturer's instructions and sequenced on an Illumina NextSeq500 platform in 75bp single-read mode.
Differential gene expression
Initial data analysis was performed on the Illumina Basespace platform using the RNA-Seq Alignment app, followed by differential gene expression analysis with edgeR. In detail, reads in fastq format were aligned to the murine reference genome version mm10, with RefSeq annotations, using STAR aligner version 2.5.0a (Dobin et al., 2013) . Reads per gene were counted, and differential gene expression was calculated using edgeR version 3.22.2 with a quasi-likelihood F-test as described by Lun et al. (2016) . Raw p values were adjusted using the Benjamini-Hochberg method to correct for multiple testing, with the false discovery rate (FDR) set to 5%.
Differentially expressed genes were displayed as a heatmap generated with MultiExperiment Viewer (MeV), a free and open-source software application available at http://mev.tm4.org/.
Gene Set Enrichment Analysis (GSEA)
GSEA is a computational pathway analysis tool that determines if a given set of manually curated genes show statistically significant, concordant differences between two biological states (Subramanian et al., 2005) and is freely accessible at http://www.broadinstitute.org/gsea/index.jsp. A custom gene set comprised of Lmo3regulated genes in mouse brain amygdalae obtained by RNA sequencing was tested for statistically significant enrichment in expression in publicly available microarray data from amygdalae derived from MDD patients or healthy controls (Chang et al., 2014) . P values and false discovery rates (FDR) for the enrichment score of the gene set were calculated based on 1000 gene set permutations. Pearson correlation was performed to investigate the relationship between latency to feed and food consumption in the NSF. Student's t-tests (two-tailed) were performed for the analysis of the qRT-PCR data, where two groups were compared.
Statistical analysis
Statistical outliers (values outside of the interval: mean ± 2 standard deviations, which covers >95% of a normal distribution) were excluded for further analysis.
Results
A reduction in anxiety-like behavior in Lmo3 z mice in the EPM has recently been reported (Savarese and Lasek, 2018) . We therefore first set out to replicate and expand this finding by including two additional established behavioral paradigms for the assessment of innate anxiety in rodents: the LDB and the OFT. A reduction in locomotor activity in Lmo3 z mice as potential confound for the performance in tests for anxiety-like behavior has been recently described (Savarese and Lasek, 2018 Fig. S2A-D) .
In order to account for the potential bias related to altered locomotor activity of Lmo3 z mice, data obtained in the EPM, LDB and OFT were analyzed in relation to the total distance travelled for each individual animal. This evaluation revealed that the relative percentage of distance travelled in the open arms of the EPM was comparable between genotypes ( Figure   1A ; genotype: p=0.8355; F(1, 41)=0.04; sex: p=0.0384; F(1,41)=4.58; genotype x sex: p=0.6354; F(1, 41)=0.23; n=9-14/group). In the LDB, Lmo3 z mice travelled significantly less distance in the light compartment relative to total distance covered than their WT littermate controls, an effect that appears to be driven by the females (Figure 1B; Given the strong epidemiological link between anxiety disorders and mood disorders (Mineka et al., 1998; Sartorius et al., 1996) , Lmo3-deficient mice were next subjected to paradigms assessing depression-like behavior. To this end the SPT, NSF and FST were employed. In the SPT, the amount of sucrose solution all mice consumed during the SPT was normalized against their body weight and no differences between Lmo3 z and control mice were found (Figure 2A, 
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We next examined depression-related anxiety in the NSF (Britton and Britton, 1981) . Here, Lmo3 z exhibited an increased average latency to feed in comparison to controls ( Figure 2B , genotype: p=0.0012; F(1, 38)=12.28; sex: p=0.7028; F(1, 38)=0.15; genotype x sex: p=0.5332;
F(1, 38)=0.40; n=9-13/group), indicating augmented depression-related anxiety. Importantly, the genetic deletion of Lmo3 z did not affect weight loss (% of initial body weight) due to food restriction prior to the NSF (Supplementary Figure S3C; For the additional evaluation of behavioral despair we turned towards the FST as a classical paradigm assessing depression-like behavior in rodents (Porsolt et al., 1977) . Here, higher levels of immobility -typically assumed to reflect heightened depression-like behavior -were revealed for Lmo3 z mice compared to WT controls ( Figure 2C; F(1, 7) =0.37; input intensity: p<0.0001; F(7, 7)=511.50; input intensity x genotype: p=0.9854; F(7, 7)=0.20; input intensity x sex: p=0.9971; F(7, 7)=0.19;
input intensity x genotype x sex: p=0.9998; F(7,7)=0.05; n=7/group).
We next sought to shed light on the molecular mechanism by which loss of Lmo3 may be associated with the observed phenotypic and functional alterations. In an unbiased screening approach based upon RNA-Seq analysis we probed the amygdala transcriptome of Lmo3 z mice in comparison to WT littermate controls. Global analysis revealed sex-specific signatures of differential gene expression, comprising 389 genes and 649 genes for female and male Lmo3 z mice in comparison to WT littermate controls, respectively. Of those, 52 genes were shared between the female and male comparisons ( Figure 4A and Supplementary Table S1 ). Pathway analysis using the Gene Ontology database of the genes differentially expressed between Lmo3 z mice in comparison to WT littermate demonstrated significant regulation of several biological processes ( Supplementary Table S2 In light of the mood-related phenotype of Lmo3 z mice we aimed to test whether genes affected by loss of Lmo3 could also play a role in human major depressive disorders (MDD).
To this end we re-analyzed a previously published amygdala microarray dataset derived from patients diagnosed with MDD and controls (Chang et al., 2014) in order to explore whether the gene expression pattern associated with Lmo3-deficiency was related to transcriptomic profile of MDD patients. Using GSEA, we tested whether the Lmo3 gene signatures derived from our Lmo3 z mice in comparison to WT littermate controls ( Figure 4A ) was enriched in previously published human microarray data (Chang et al., 2014) . Indeed, Figure 4A shows that the genes expressed at higher levels in Lmo3 z mice (shown in Supplementary table S1) were significantly enriched in amygdala tissue of human patients suffering from MDD (both J o u r n a l P r e -p r o o f p<0.01) (Chang et al., 2014) (Figure 4C and Supplementary Table S1 : tab 'females&males'overlap: grey shaded genes).
qRT-PCR-based confirmation of RNA-Seq results was performed for selected genes as proofor-principle, which demonstrated the expected highly significant downregulation of Lmo3 together with exclusive expression of LacZ in Lmo3 z mice ( Figure 4D; Lmo3 -p<0 
Discussion
We here comprehensively characterized innate anxiety and learned fear as well as depression-related phenotypes in a mouse model of genetic Lmo3 depletion. The obtained data point towards augmented anxiety-and depression-like behaviors in Lmo3-deficient mice, albeit the behavioral data have to be interpreted with caution in light of a reduction in overall locomotor activity in Lmo3 z mice. Additionally, and in agreement with the altered emotional behavioral displays of Lmo3 z mice, we found a disruption in neural activity in the BLA, which was paralleled by a gene expression signature showing a significant overlap with amygdalar transcriptome changes in MDD patients. Additionally, a pathway analysis on the gene set differentially expressed between Lmo3 z and WT mice -which highlighted the important role of Lmo3 in brain development -also revealed pathways relating to neural morphology. Hence, it is plausible that the functional aberrations observed in Lmo3 z mice may reflect corresponding structural deviations in Lmo3-deficient BLA neurons with relevance for synaptic plasticity and respective plasticity-dependent learning processes (eg.
fear conditioning).
A seminal study relating the transcription factor Lmo3 to the regulation on emotions and putting its major focus on addiction-related behavior has previously reported enhanced ethanol sensitivity and increased consumption in Lmo3-deficient (Lmo3 z ) mice (Savarese et al., 2014) . Considering the intricate relationship between addiction and anxiety, with anxiety disorders being correlated to higher lifetime rates of alcohol abuse (for a systematic review see Lai et al., 2015) and alcohol augmenting the symptoms of anxiety, enhanced anxiety-like behavior would be expected in Lmo3 z mice. Indeed, in contrast to a previous report (Savarese and Lasek, 2018) , we did observe an altered performance of Lmo3 z mice indicating an increase in anxiety-like behavior in several well-validated and robust paradigms.
However, the decreased locomotor activity of Lmo3 z mice, which we confirmed in the present study, has to be considered as potential confound for the results obtained in the anxiety tests. Alternatively, one also has to contemplate the possibility that the altered locomotor activity itself could result from a state of heightened baseline anxiety, in which case the reduced activity could be considered as specific display, rather than as unspecific bias. In either case, the normalization of the results obtained in the anxiety tests with regards to the total distance travelled by the individual animal aimed to account for baseline differences in locomotion, and the data suggests a phenotype of augmented anxiety in Lmo3 z mice. The additional indications of behavioral displays observed in Lmo3 z mice and typically associated with augmented depression-like behavior in the NSF and the FST, carefully vetted against potential confounds delineated above, are also in agreement with the high degree of comorbidity between anxiety and mood disorders in the human population (Mineka et al., 1998; Sartorius et al., 1996) .
The observation that the present results appear in contrast to previous reports on innate anxiety in Lmo3 z mice (Savarese and Lasek, 2018) is intriguing and may be explained by technical differences in the specific behavioral paradigms applied, as well as discrepancies in basic mouse husbandry such as the duration of the light-dark cycle (12:12 vs. 14:10) or housing conditions (single vs. group-housed), variables known to significantly impact the anxiety-related behavioral performance (Nagy et al., 2002; Võikar et al., 2005; Wahlsten et al., 2003) . This consideration could also suggest a differential susceptibility of Lmo3 z mice to anxiogenic/ stress-inducing conditions, which would be interesting to specifically explore in a follow-up study.
Further supporting the interpretation that the dampened locomotor activity in Lmo3 z mice did not bias the specific emotional tasks are the results obtained in the fear conditioning paradigm, where Lmo3 z mice moved more than their WT littermates in response to the presentation of the CS in the in cue-dependent recall test. However, very high levels of pre-CS freezing may complicate the interpretation of the cued recall after conditioning due to a "ceiling effect". However, pre-CS freezing in male Lmo3 z mice is on average below 20%, leaving sufficient room for a detectable increase in response to the CS delivery, albeit it has to be noted that the enhanced preCS freezing does contribute to the observed reduction in the CS-preCS freezing in comparison to WT animals.
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A reduction in stimulus-dependent freezing behavior, which is inherently dependent on the amygdala (Rogan et al., 1997; Rogan and LeDoux, 1995) , is indicative of a deficient learned fear response. This behavioral phenotype is also mirrored by a dramatic dysfunction at the neural network level, reflected in an impairment of BLA-LTP in Lmo3 z mice. Interestingly, despite an overall genotype effect for the results of the cued fear recall test as well as for BLA-LTP the phenotype of male Lmo3 z mice appears more pronounced than the one of the females, when compared to their respective WT littermate counterpart, albeit only reflected in a statistically significant genotype x sex interaction in the fear conditioning performance.
In contrast, the display of innate anxiety was more apparent in female than in male Lmo3deficient animals, tentatively proposing a sex-specific function of Lmo3 in the regulation of emotions.
Indeed, sex differences were also observed for the amygdala gene expression patterns in Lmo3 z mice which however yielded the astounding revelation that the genes differentially expressed in both male and female Lmo3 z amygdala compared to WT showed a significant overlap with a set of genes previously shown to be dysregulated in amygdala tissue derived from an MDD patient cohort (Chang et al., 2014) . Among the genes accounting for this association is Lmo3 itself which puts forward the possibility that Lmo3, possibly through its function as a transcription factor highly conserved between mouse and man (Foroni et al., 1992) , may be directly involved in the regulation of gene networks that collectively appear to be disturbed in the amygdalae of MDD patients.
Among the molecular elements additionally accounting for this association are the genes encoding aspartoacylase (ASPA), protein phosphatase 1 regulatory inhibitor subunit 14A (PPP1R14A), pleckstrin homology and RhoGEF domain containing G3 (PLEKHG3) and encephalopsin (OPN3). The fact that ASPA is expressed in oligodendrocytes and associated primarily with leukodystrophy (reviewed in Moffett et al., 2007) suggests examining myelination in Lmo3 z mice in future studies, as deficient myelination could account for the observed motor impairment. Curiously, abnormalities in brain myelin content have been also repeatedly found in MDD patients (e.g. Jiang et al., 2018; Rajkowska et al., 2015; Sacchet and Gotlib, 2017; Williams et al., 2019) . PPP1R14a is also considered an oligodendrocyte marker gene, further supporting a potential relevance of myelination and respective deficits in this context. PLEKHG3 on the other hand is a protein involved in cell migration, which could be of relevance for the neurodevelopmental role of Lmo3 (Dawid et Foroni et al., 1992) and may also relate to its suggested role in cell migration and cell growth in the context of cancer proliferation (Aoyama et al., 2005; Chen et al., 2019; Song et al., 2015) . The involvement of OPN3, a retina-and brain-expressed light-sensitive transmembrane receptor with relevance for the regulation of circadian rhythmicity (Flyktman et al., 2015) , is particularly noteworthy considering reports of irregular circadian rhythm in dLmo-mutant Drosophila (Tsai et al., 2004) and the broad consensus that disruptions in the circadian rhythm and in the quality of sleep play an important role in neuropsychiatric disorders, including MDD (reviewed in Wulff et al., 2010) .
Whether Lmo3 dysregulation is causally involved in some of these aberrations, and thus might represent a genetic risk factor, or whether Lmo3 itself is regulated by another separate mechanism that becomes dysfunctional in MDD patients remains to be further explored, both at the levels of basic research as well as large-scale genetic association studies in the human population. Relative expression levels of selected targets in the amygdala of female Lmo3 z mice (RNA-Seq female cohort extended by several Lmo3 z and WT mice). Data is shown as mean ± SD; significance levels obtained by individual t tests are displayed: * p<0.05; ** p<0.01; *** p<0.0001. GSEA: gene set enrichment analysis, MDD: major depressive disorder.
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